Cadila Healthcare, through its 100% subsidiary Zydus Animal Health (ZAHL) has signed a share purchase agreement with ICICI Venture, to acquire 100% shareholding of Finest Procuring Solutions, which in turn holds 100% shareholding of Bremer Pharma GmbH, of Germany. The agreement includes the transfer of all key assets, people, brands and export contracts of Bremer - a global animal health company headquartered in Warburg-Scherfede, Germany.
The acquisition will help Zydus AHL to expand its animal health business and gain strategic access to the key markets across Europe, South America, Asia and Africa. The global animal health business is valued at $20 billion.
With a proven track record in poultry and livestock business, Bremer Pharma has over 500 registrations and an extensive network of distributors in more than 50 countries. The company has well established research facilities and infrastructure for manufacturing powders, tablets, liquid and parenterals in Warburg-Scherfede, Germany.
Cadila Pharmaceuticals focuses on various areas, such as formulations (human and veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1532.85 |
Dr. Reddys Lab | 5812.50 |
Cipla | 1403.90 |
Zydus Lifesciences | 1104.45 |
Lupin | 1661.90 |
View more.. |